Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
NeoTherma Oncology
AddedFeb 15, 2024
UpdatedJun 18, 2026
NeoTherma Oncology

NeoTherma Oncology

Series A

NeoTherma Oncology develops VectRx™, a noninvasive thermal device for diverse cancer treatments.

HQ
Wichita, KS, US
Founded
2015
Overview
Compare
Fundraising
Employees

NeoTherma Oncology's core mission is to revolutionize cancer treatment through noninvasive thermal therapy. They develop VectRx™, a device system designed to treat various cancers, including Pancreatic Ductal Adenocarcinoma. Their market focus is on providing innovative, noninvasive solutions to enhance cancer care.

NeoTherma Oncology has achieved significant milestones in developing VectRx™, positioning itself as a leader in thermal oncology therapy. The company's impact includes advancing noninvasive treatment options, potentially improving patient outcomes and quality of life.

NeoTherma Oncology - Similar Companies

Verthermia logo

Verthermia

verthermia.com

Neoantigenics logo

Neoantigenics

ViaTherm Therapeutics logo

ViaTherm Therapeutics

Thermaquil logo

Thermaquil

thermaquil.com

Autem Therapeutics logo

Autem Therapeutics

ThermalTherapeutic Systems logo

ThermalTherapeutic Systems

Neonc Technologies logo

Neonc Technologies

neonctech.com

Thermedical logo

Thermedical

thermedical.com

TheraBionic logo

TheraBionic

Nerx Biosciences logo

Nerx Biosciences

Theromics logo

Theromics

theromicsinc.com

PNP Therapeutics logo

PNP Therapeutics

Kaio Therapy logo

Kaio Therapy

kaiotherapy.com

Neuright logo

Neuright

neurightlabs.com

Palm Therapeutics logo

Palm Therapeutics

NeoTherma Oncology - Quick Facts

Who are NeoTherma Oncology's competitors?

Companies similar to NeoTherma Oncology include Verthermia, Neoantigenics, ViaTherm Therapeutics and Thermaquil.

When was NeoTherma Oncology founded?

NeoTherma Oncology was founded in 2015.

Where is NeoTherma Oncology's headquarters located?

NeoTherma Oncology's headquarters is located in Wichita, KS, US.

When was NeoTherma Oncology's last funding round?

NeoTherma Oncology's most recent funding round was for $6M (USD) in August 2018.

How much has NeoTherma Oncology raised to-date?

As of Aug 20, 2018, NeoTherma Oncology has raised a total of $6M (USD).

How many employees does NeoTherma Oncology have?

NeoTherma Oncology has 9 employees as of Feb 4, 2024.

NeoTherma Oncology - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Analytics
  • HealthTech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Biotech
  • Healthcare
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research